(a) Notwithstanding this part to the contrary, the committee or the commissioner:

lawyer at desk

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

Terms Used In Tennessee Code 53-10-308

  • Board: means the board of pharmacy created by title 63, chapter 10, part 3. See Tennessee Code 53-10-302
  • Commissioner: means the commissioner of health. See Tennessee Code 53-10-302
  • Committee: means the controlled substance database committee created by §. See Tennessee Code 53-10-302
  • Controlled substances: means a drug, substance, or immediate precursor in Schedules I through VI defined or listed in the Tennessee Drug Control Act of 1989, compiled in title 39, chapter 17, part 4. See Tennessee Code 53-10-302
  • Database: means the controlled substance database created by §. See Tennessee Code 53-10-302
  • Department: means the department of health. See Tennessee Code 53-10-302
  • Law enforcement personnel: means agents of the Tennessee bureau of investigation, agents of a judicial district drug task force, drug enforcement administration agents, and certified law enforcement officers certified pursuant to §. See Tennessee Code 53-10-302
  • Litigation: A case, controversy, or lawsuit. Participants (plaintiffs and defendants) in lawsuits are called litigants.
  • Reporter: Makes a record of court proceedings and prepares a transcript, and also publishes the court's opinions or decisions (in the courts of appeals).
  • Settlement: Parties to a lawsuit resolve their difference without having a trial. Settlements often involve the payment of compensation by one party in satisfaction of the other party's claims.
  • State: when applied to the different parts of the United States, includes the District of Columbia and the several territories of the United States. See Tennessee Code 1-3-105
(1) May release confidential information from the database regarding healthcare practitioners, healthcare practitioner delegates, or patients to department personnel engaged in an investigation, adjudication, or prosecution of a violation under any state or federal law that involves a controlled substance;
(2) May release confidential information from the database regarding healthcare practitioners, healthcare practitioner delegates, or patients to law enforcement personnel engaged in an investigation, adjudication, or prosecution of a violation under any state or federal law that involves a controlled substance, pursuant to the procedure established in § 53-10-306(a)(11);
(3) Shall release information from the database when ordered by a court to do so upon the court’s finding that disclosure is necessary for the conduct of proceedings before the court regarding the investigation, adjudication, or prosecution of a violation under any state or federal law that involves controlled substances and after an appropriate protective order is issued regarding the information to be released to the court; and
(4)

(A) Shall release confidential information from the database to the attorney general and reporter upon request for the purpose of reviewing, querying, or otherwise using the data in conjunction with investigating or litigating a civil action involving controlled substances. The data may be disclosed at the attorney general and reporter’s discretion to:

(i) Designees within the office of the attorney general and reporter who are participating in, assisting with, or supervising any such investigation or litigation;
(ii) Other parties to litigation to which the attorney general and reporter is a party in which the data is relevant so long as disclosure of the data is in furtherance of litigation or resolution of litigation, and the data is provided only after an appropriate protective order is issued prohibiting the other parties from using the confidential information for any purpose other than defending or resolving the litigation and prohibiting the sharing of confidential information with litigants in other cases or other parties;
(iii) Targets of an investigation conducted by the attorney general and reporter for the purpose of negotiating a settlement regarding conduct to which the data is relevant only after an appropriate protective order is issued or a confidentiality agreement is executed regarding the data;
(iv) Designated consultants or experts who agree to maintain the confidentiality of the data and who are retained, in conjunction with an investigation or litigation, by:

(a) The attorney general and reporter;
(b) Other parties to litigation to which the attorney general and reporter is a party as described in subdivision (a)(4)(A)(ii); or
(c) Targets of an investigation conducted by the attorney general and reporter as described in subdivision (a)(4)(A)(iii); and
(v) A court for evidentiary or other purposes after an appropriate protective order is issued regarding the confidential information;
(B) The attorney general and reporter shall comply with the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.) to the extent that it applies to any such disclosure.
(b) Any data authorized to be released under this section or § 53-10-306, other than deidentified data or data released to personnel of the department, the attorney general and reporter, or a health-related board is limited to reports of drugs prescribed to specific patients or prescribed by specific providers, and nothing in this part creates a right to other data such as provider query audits or registration information, nor does anything in this part require the committee or department to provide analytics or analysis of any data available in the database.
(c) Data reported to the database by a Part 2 Program shall not be released under this section or § 53-10-306 unless such release complies with 42 C.F.R. part 2 and the rules promulgated by the commissioner pursuant to § 53-10-304(e).
  Previous section
Next section  
 Part 3 Contents